Clinical evaluation of p16INK4a immunocytology in cervical cancer screening: A population‐based cross‐sectional study from rural China.

MLA

Rezhake, Remila, et al. “Clinical Evaluation of P16INK4a Immunocytology in Cervical Cancer Screening: A Population‐based Cross‐sectional Study from Rural China.” Cancer Cytopathology, vol. 129, no. 9, Sept. 2021, pp. 679–92. EBSCOhost, https://doi.org/10.1002/cncy.22428.

APA

Rezhake, R., Wang, Y., Chen, F., Hu, S., Zhang, X., Cao, J., Qiao, Y., Zhao, F., & Arbyn, M. (2021). Clinical evaluation of p16INK4a immunocytology in cervical cancer screening: A population‐based cross‐sectional study from rural China. Cancer Cytopathology, 129(9), 679–692. https://doi.org/10.1002/cncy.22428

Chicago

Rezhake, Remila, Yan Wang, Feng Chen, Shang‐Ying Hu, Xun Zhang, Jian Cao, You‐Lin Qiao, Fang‐Hui Zhao, and Marc Arbyn. 2021. “Clinical Evaluation of P16INK4a Immunocytology in Cervical Cancer Screening: A Population‐based Cross‐sectional Study from Rural China.” Cancer Cytopathology 129 (9): 679–92. doi:10.1002/cncy.22428.